Sato J, Azuma K, Kinowaki K, Ikeda K, et al. Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting
Prognosis of Patients With Estrogen Receptor-positive Breast Cancer. Clin Breast Cancer 2020 Dec 9. pii: S1526-8209(20)30328.
PMID: 33386231